6176
B. Breit, S. K. Zahn / Tetrahedron 61 (2005) 6171–6179
0
.007 mmol) was obtained after 24 h 328 mg (70%) of
CDCl ): dZ0.66 – 0.80 (m, 9H, 3!CH ), 0.97 (m , 1H),
3 3 c
1
ketone (G)-17 (dr (syn/anti)Z94:6). H NMR (300 MHz,
CDCl ): dZ0.67–0.82 (m, 9H, 3!CH ), 0.97 (m , 1H),
1.13 (t, JZ7.1 Hz, 3H), 1.50 (m , 2H), 1.68 (m , 1H), 1.82
c c
(m , 1H), 2.00–2.09 (m, 3H), 4.00 (q, JZ7.1 Hz, 2H,
3
3
c
c
1
.08 (m , 1H), 1.43 (m , 2H), 1.65 (m , 1H), 1.80 (m , 1H),
CH O), 4.71 (dd, JZ7.5, 4.4 Hz, 1H), 6.82 (m , 1H, Ar-H),
c
c
c
c
2
c
1
.97 (s, 3H, CH C(O)), 2.10–2.20 (m, 2H, CH ), 4.72 (dd,
3
7.14–7.22 (m, 10H, Ar-H), 7.28 (m , 2H, Ar-H), 8.00 (m ,
2
c c
1
3
JZ7.8, 4.1 Hz, 1H), 6.82 (m , 1H, Ar-H), 7.10–7.20 (m,
1H, Ar-H). C NMR (75.469 MHz, CDCl ): dZ3.5, 13.9,
c
3
1
3
1
0H, Ar-H), 7.26 (m , 2H, Ar-H), 8.01 (m , 1H, Ar-H).
C
17.9, 19.2, 22.2, 29.3, 32.8, 33.9, 34.0, 59.8, 81.7, 127.7,
c
c
3
NMR (75.469 MHz, CDCl ): dZ13.6, 18.3, 19.1, 21.3,
128.0–128.2 (7 C), 130.4 (d, J Z1.8 Hz), 131.4, 133.5
3
C,P
2
2
2
1
1
9.1, 29.4, 33.1, 34.2, 43.6, 81.8, 128.0, 128.1–128.5 (5C),
28.9, 130.2, 131.7, 133.3 (d, J Z21.5 Hz, 2C), 133.9,
34.0 (d, J Z25.8 Hz, 2C), 134.2, 138.0 (d, JC,PZ
(d, JC,PZ19.4 Hz, 2C), 133.8 (d, JC,PZ21.2 Hz, 2C),
2
1 1
133.9, 137.9 (d, J Z12.6 Hz), 138.0 (d, JC,PZ12.1 Hz),
C,P
2 3
C,P
2
1
140.9 (d, J Z28.1 Hz), 166.0 (d, JC,PZ2.9 Hz), 173.2
C,P
C,P
1
31
1
0.3 Hz), 138.2 (d,
JC,P27.9 Hz), 166.3, 208.7. P NMR (81.015 MHz,
JC,PZ11.8 Hz), 141.0 (d,
(CO Et). P NMR (81.015 MHz, CDCl ): dZK3.0 (s).
2
3
2
31
C H O P (504.6). Calcd C 73.79, H 7.39; found C 73.60,
H 7.54.
31 37 4
CDCl ): dZK2.9 (s). C H O P (474.58). Calcd C
3
30 35 3
7
5.93, H 7.43; found C 75.91, H 7.72.
4
.2.8. (1R*,3S*)-(G)-1-Isopropyl-2-methyl-7-oxooctyl-
4
1
.2.5. (1R*,2S*)-(G)-1-[(1R*)-2-tert-Butylcarbonyloxy)-
-methyl-ethyl]-2-methyl-6-oxoheptyl-[2-(diphenyl-
[2-(diphenylphosphanyl)]benzoate ((G)-24). From
o-DPPB ester (G)-23 (458 mg, 1.1 mmol), ylide 16
(525 mg, 1.65 mmol), [RhH(CO)(PPh ) ] (7.1 mg,
phosphanyl)]benzoate ((G)-18). From o-DPPB ester (G)-
(352 mg, 0.7 mmol), ylide 16 (334 mg, 1.05 mmol),
RhH(CO)(PPh ) ] (4.5 mg, 0.0049 mmol) was obtained
3
3
9
[
0.0077 mmol) was obtained after 48 h at 50 8C and 48 h at
70 8C 441 mg (82%) of ketone (G)-24 (dr (anti/syn)Z
3
3
1
after 28 h 274 mg (68%) of ketone (G)-18 (dr (syn/anti)Z
91:9). H NMR (300 MHz, CDCl ): dZ0.76 (d, JZ6.4 Hz,
3
1
9
6:4). H NMR (300 MHz, CDCl ): dZ0.84 (d, JZ6.8 Hz,
3H, CH ), 0.82 (d, JZ6.8 Hz, 6H, 2!CH ), 1.08–1.79 (m,
3
3
3
3
CH, C(CH ) ), 1.44–1.77 (m, 3H), 2.09 (s, 3H, CH ), 2.14
H, CH ), 0.88 (d, JZ6.8 Hz, 3H, CH ), 1.14–1.26 (m, 10H,
8H), 2.08 (s, 3H, CH ), 2.36 (pt, JZ7.5 Hz, 2H), 4.98 (m ,
3
3
3
c
1H), 6.90 (m , 1H, Ar-H), 7.24–7.33 (m, 10H, Ar-H), 7.39
c
3
3
3
1
3
(
OCH ), 5.04 (m , 1H), 6.90 (m , 1H, Ar-H), 7.21–7.32 (m,
m , 1H, CH), 2.26–2.35 (m, 3H), 3.77–3.91 (m, 2H,
(m , 2H, Ar-H), 8.06 (m , 1H, Ar-H).
c
C NMR
(75.469 MHz, CDCl ): dZ17.9, 18.4, 19.2, 21.2, 29.1,
c
c
2
c
c
3
1
3
1
0H, Ar-H), 7.40 (m , 2H, Ar-H), 8.06 (m ,1H, Ar-H).
c
C
29.8, 32.2, 37.2, 38.1, 44.0, 77.4, 128.1, 128.4–128.5 (8
c
2
NMR (75.469 MHz, CDCl ): dZ12.7, 14.3, 21.2, 27.2 (3!
Ar-C), 130.5, 131.7, 133.9 (d, J Z20.8 Hz, 2C), 134.1
3
C,P
2
1
CH ), 33.0, 34.5, 34.7, 38.7, 43.7, 49.4, 66.2, 77.8, 128.0,
1
(d, J Z20.8 Hz, 2C), 134.3, 138.3 (d, J Z12.1 Hz,
C,P C,P
3 31
2C), 167.8 (d, JC,PZ3.0 Hz), 208.9.
3
2
28.1–128.5 (7 Ar-C), 128.6, 130.5, 131.9, 133.9 (d, JC,PZ
0.6 Hz, 4C), 134.3, 137.9 (d, J Z12.0 Hz), 141.0 (d,
JC,PZ28.0 Hz), 166.0 (d, JC,PZ2.7 Hz), 178.2, 208.7.
P NMR
1
2
(81.015 MHz, CDCl ): dZK3.3 (s). C H O P (488.6).
C,P
3
31 37 3
2
3
31
P
Calcd C 76.20, H 7.63; found C 75.96, H 7.42.
NMR (81.015 MHz, CDCl ): dZK3.1 (s). C H O P
3
35 43 5
(
574.7). Calcd C 73.15, H 7.54; found C 73.02, H 7.60.
4.2.9. (6S*)-(G)-6-[(2R*,4S*,5R*)-5-Methyl-2-phenyl-
1,3]-dioxan-4-yl]-heptan-2-one ((G)-26). From benzyl-
idene acetal (G)-25 (218 mg, 1.0 mmol), ylide 16 (478 mg,
1.5 mmol), [RhH(CO)(PPh ] (6.4 mg, 0.007 mmol) was
[
4.2.6. (1R*,2S*)-(G)-1-[(1R*)-1-(Ethyloxycarbonyl)-
ethyl]-2-methyl-6-oxoheptyl-[2-(diphenylphosphanyl)]-
)
3 3
benzoate ((G)-20). From o-DPPB ester (G)-12 (461 mg,
1
obtained after 48 h at 50 8C and 48 h at 70 8C 174 mg (78%,
based on 77% conversion) of ketone (G)-26 (dr (anti/
.0 mmol),
RhH(CO)(PPh ) ] (6.4 mg, 0.007 mmol) was obtained
ylide
16
(414 mg,
1.3 mmol),
1
[
after 23 h 316 mg (59%) of ketone (G)-20 (dr (syn/
syn)ZO98:2). H NMR (300 MHz, CDCl
3
): dZ0.76 (d,
), 1.08 (d, JZ6.9 Hz, 3H, CH ), 1.26–
1.59 (m, 3H), 1.66–1.84 (m, 3H), 2.00–210 (m, 1H), 2.13 (s,
3H, CH C(O)), 2.43 (pt, JZ7.1 Hz, 2H), 3.35 (dd, JZ
10.0 Hz, 1H), 3.48 (pt, JZ11.0 Hz, 1H), 5.45 (s, 1H), 7.31–
3
3
JZ6.7 Hz, 3H, CH
3
3
1
anti)Z94:6). H NMR (300 MHz, CDCl ): dZ0.82 (d,
3
JZ6.8 Hz, 3H, CH ), 1.07–1.13 (m, 8H), 1.55 (pseudo
3
3
quint., JZ7.9 Hz, 2H), 1.75 (m , 1H), 2.10 (s, 3H,
c
1
3
CH C(O)), 2.29 (m , 2H), 2.83 (m , 1H), 3.97 (m , 2H),
5
7.38 (3H, Ar-H), 7.46–7.49 (2H, Ar-H). C NMR
(75.469 MHz, CDCl ): dZ12.2, 17.0, 22.1, 29.2, 29.8,
30.6, 33.8, 44.0, 73.2, 87.7, 101.2, 126.0 (2C), 128.1 (2C),
128.5, 139.0, 209.4. C18 (290.4). Calcd C 74.45, H
9.02; found C 74.40, H 8.92.
3
c
c
c
.23 (dd, JZ8.3, 3.9 Hz, 1H), 6.90 (m , 1H, Ar-H), 7.19–
3
c
7
.32 (m, 10H, Ar-H), 7.37 (m , 2H, Ar-H), 8.08 (m , 1H,
c
c
1
3
Ar-H). C NMR (75.469 MHz, CDCl ): dZ13.5, 13.9,
H O
26 3
3
1
1
2
4.0, 21.4, 27.0, 32.9, 34.3, 42.3, 43.7, 60.6, 77.7, 128.0,
Z
2
28.2–128.4 (8 Ar-C), 130.5, 131.8, 133.7 (d, JC,P
2
0.7 Hz, 2C), 133.9 (d, J Z21.0 Hz, 2C), 134.2, 138.0
4.3. Regioselective domino hydroformylation–Wittig
olefination–hydrogentation of silylether 11
C,P
1
1
(
d, JC,PZ12.4 Hz), 138.2 (d, JC,PZ12.7 Hz), 165.5,
3
1
1
73.6, 208.8. P NMR (81.015 MHz, CDCl ): dZK3.7
3
(
7
s). C H O P (532.6). Calcd C 72.16, H 7.00; found C
1.99, H 6.91.
4.3.1. Preparation of 10-(tert-butyldimethylsilyloxy)-
decane-2-one (12). To a solution of [Rh(CO) acac]
3
2 37 5
2
(1.3 mg, 0.005 mmol) in THF (2 ml) was added at rt
4
2
2
2
0
.2.7. (1R*,2R*)-(G)-5-(Ethyloxycarbonyl)-1-isopropyl-
-methylpentyl-[2-(diphenylphosphanyl)]benzoate ((G)-
2). From o-DPPB ester (G)-4 (402 mg, 1.0 mmol), ylide
1 (523 mg, 1.5 mmol), [RhH(CO)(PPh ) ] (6.4 mg,
BIPHEPHOS (15.7 mg, 0.002 mmol). Subsequently alkene
11 (106 mg, 0.5 mmol) and ylide 16 (191 mg, 0.6 mmol)
was added. The resulting solution was transferred with
additional THF (2 ml) into the autoclave. Hydroformylation
was performed during 4 d at 60 8C to give after the usual
workup 103 mg (72%) of the methylketone 12 (rsR98:2) as
3
3
.007 mmol) was obtained after 24 h 328 mg (36%) of
1
ester (G)-22 (dr (syn/anti)Z95:5). H NMR (300 MHz,